Jalving M - Search Results

1

High-grade dysplasia in sporadic fundic gland polyps: a case report and review of the literature.

Jalving M, Koornstra JJ, Götz JM, van der Waaij LA, de Jong S, Zwart N, Karrenbeld A, Kleibeuker JH. Jalving M, et al. Eur J Gastroenterol Hepatol. 2003 Nov;15(11):1229-33. doi: 10.1097/00042737-200311000-00013. Eur J Gastroenterol Hepatol. 2003. PMID: 14560158 Review.

2

Expression of tumour necrosis factor-related apoptosis-inducing ligand death receptors in sporadic and hereditary colorectal tumours: potential targets for apoptosis induction.

Koornstra JJ, Jalving M, Rijcken FE, Westra J, Zwart N, Hollema H, de Vries EG, Hofstra RW, Plukker JT, de Jong S, Kleibeuker JH. Koornstra JJ, et al. Among authors: jalving m. Eur J Cancer. 2005 May;41(8):1195-202. doi: 10.1016/j.ejca.2005.02.018. Eur J Cancer. 2005. PMID: 15911244

3

TRAIL induces apoptosis in human colorectal adenoma cell lines and human colorectal adenomas.

Jalving M, de Jong S, Koornstra JJ, Boersma-van Ek W, Zwart N, Wesseling J, de Vries EG, Kleibeuker JH. Jalving M, et al. Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4350-6. doi: 10.1158/1078-0432.CCR-05-2487. Clin Cancer Res. 2006. PMID: 16857810

4

Metformin: taking away the candy for cancer?

Jalving M, Gietema JA, Lefrandt JD, de Jong S, Reyners AK, Gans RO, de Vries EG. Jalving M, et al. Eur J Cancer. 2010 Sep;46(13):2369-80. doi: 10.1016/j.ejca.2010.06.012. Epub 2010 Jul 23. Eur J Cancer. 2010. PMID: 20656475 Review.

5

Heijink DM, Jalving M, Oosterhuis D, Sloots IA, Koster R, Hollema H, Kleibeuker JH, Koornstra JJ, de Vries EG, de Jong S. Heijink DM, et al. Among authors: jalving m. J Pathol. 2011 Feb;223(3):378-89. doi: 10.1002/path.2797. Epub 2010 Oct 29. J Pathol. 2011. PMID: 21171083

6

Low-dose triple drug combination targeting the PI3K/AKT/mTOR pathway and the MAPK pathway is an effective approach in ovarian clear cell carcinoma.

Caumanns JJ, van Wijngaarden A, Kol A, Meersma GJ, Jalving M, Bernards R, van der Zee AGJ, Wisman GBA, de Jong S. Caumanns JJ, et al. Among authors: jalving m. Cancer Lett. 2019 Oct 1;461:102-111. doi: 10.1016/j.canlet.2019.07.004. Epub 2019 Jul 15. Cancer Lett. 2019. PMID: 31319139 Free article.

7

Pyruvate Dehydrogenase Kinase Inhibition by Dichloroacetate in Melanoma Cells Unveils Metabolic Vulnerabilities.

Tiersma JF, Evers B, Bakker BM, Jalving M, de Jong S. Tiersma JF, et al. Among authors: jalving m. Int J Mol Sci. 2022 Mar 29;23(7):3745. doi: 10.3390/ijms23073745. Int J Mol Sci. 2022. PMID: 35409102 Free PMC article.

8

Everolimus decreases [U-¹³C]glucose utilization by pyruvate carboxylase in breast cancer cells in vitro and in vivo.

Ariaans G, Tiersma JF, Evers B, Gerding A, Waaijer SJH, Koster RA, Touw DJ, Bakker BM, Reijngoud DJ, de Jong S, Jalving M. Ariaans G, et al. Among authors: jalving m. Biomed Pharmacother. 2024 Apr;173:116362. doi: 10.1016/j.biopha.2024.116362. Epub 2024 Mar 2. Biomed Pharmacother. 2024. PMID: 38432130 Free article.

9

Sulfonylurea derivatives and cancer, friend or foe?

Hendriks AM, Schrijnders D, Kleefstra N, de Vries EGE, Bilo HJG, Jalving M, Landman GWD. Hendriks AM, et al. Among authors: jalving m. Eur J Pharmacol. 2019 Oct 15;861:172598. doi: 10.1016/j.ejphar.2019.172598. Epub 2019 Aug 10. Eur J Pharmacol. 2019. PMID: 31408647 Free article.

10

Anti-tumor effects of everolimus and metformin are complementary and glucose-dependent in breast cancer cells.

Ariaans G, Jalving M, Vries EG, Jong S. Ariaans G, et al. Among authors: jalving m. BMC Cancer. 2017 Mar 29;17(1):232. doi: 10.1186/s12885-017-3230-8. BMC Cancer. 2017. PMID: 28356082 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

91 results

Search Page